We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,055 hedge funds and large institutions have $51.5B invested in Thermo Fisher Scientific in 2016 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 384 increasing their positions, 421 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 38

34% more call options, than puts

Call options by funds: $233M | Put options by funds: $174M

5% more capital invested

Capital invested by funds: $48.9B → $51.5B (+$2.6B)

3% more funds holding

Funds holding: 1,0241,055 (+31)

1% more funds holding in top 10

Funds holding in top 10: 7778 (+1)

9% less repeat investments, than reductions

Existing positions increased: 384 | Existing positions reduced: 421

2.57% less ownership

Funds ownership: 91.36%88.79% (-2.6%)

Holders
1,055
Holders Change
+31
Holders Change %
+3.03%
% of All Funds
28.15%
Holding in Top 10
78
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+1.3%
% of All Funds
2.08%
New
79
Increased
384
Reduced
421
Closed
38
Calls
$233M
Puts
$174M
Net Calls
+$59M
Net Calls Change
+$99.8M
Name Holding Trade Value Shares
Change
Change in
Stake
GF
226
Gabelli Funds
New York
$18.3M -$1.05M -7,100 -5%
SG
227
Swarthmore Group
Pennsylvania
$18.1M -$6.49M -44,000 -26%
WSFS
228
Wilmington Savings Fund Society
Delaware
$18M +$70.4K +477 +0.4%
TCT
229
TIAA CREF Trust
Missouri
$17.8M +$178K +1,203 +1%
WJA
230
Williams Jones & Associates
New York
$17.8M +$519K +3,515 +3%
GIBU
231
Gulf International Bank (UK)
United Kingdom
$17.8M
ESCM
232
Echo Street Capital Management
New York
$17.5M -$6.95M -47,109 -28%
GIA
233
Guyasuta Investment Advisors
Pennsylvania
$17.4M +$76.9K +521 +0.4%
NIPH
234
NN Investment Partners Holdings
Netherlands
$17.3M +$247K +1,671 +1%
UCFA
235
United Capital Financial Advisors
Texas
$17.2M -$210K -1,421 -1%
Los Angeles Capital Management
236
Los Angeles Capital Management
California
$17M -$14.8K -100 -0.1%
Janney Montgomery Scott
237
Janney Montgomery Scott
Pennsylvania
$16.9M +$9.31M +63,066 +122%
FA
238
Friess Associates
Delaware
$16.9M
AP
239
Atwood & Palmer
Missouri
$16.9M -$25.7K -174 -0.2%
GJCM
240
Grand Jean Capital Management
California
$16.8M
Handelsbanken Fonder
241
Handelsbanken Fonder
Sweden
$16.7M -$738K -5,000 -4%
VRS
242
Virginia Retirement Systems
Virginia
$16.7M +$16.6M +112,800 New
Asset Management One
243
Asset Management One
Japan
$16.7M -$160K -1,084 -0.9%
FQ
244
First Quadrant
California
$16.5M -$708K -4,800 -4%
AIM
245
abrdn Investment Management
United Kingdom
$16.4M -$54.5K -369 -0.3%
QC
246
Quadrature Capital
United Kingdom
$16.3M +$16.3M +110,488 New
ASRS
247
Arizona State Retirement System
Arizona
$16.3M -$1.46M -9,900 -8%
SLAM
248
Swiss Life Asset Management
$16.1M
AIM
249
Artemis Investment Management
United Kingdom
$15.8M -$664K -4,498 -4%
Fiera Capital (Canada)
250
Fiera Capital (Canada)
Quebec, Canada
$15.8M +$1.82M +12,330 +13%

TMO Hedge Fund Activity: Q2 2016 in Review

1,055 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2016, worth a combined $51.5B — up 5.3% from $48.9B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new TMO positions and 38 closed out — a net gain of 41 holders — while 384 added to existing stakes and 421 trimmed.

The largest buyer was Sound Shore Management, adding an estimated $180M. The largest seller was Royal London Asset Management, cutting an estimated $2.01B.

  • 1,055 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2016, up from 1,024 in Q1 2016.
  • Funds reported $51.5B of Thermo Fisher Scientific stock for Q2 2016, up 5.3% quarter-over-quarter.
  • 79 funds opened new Thermo Fisher Scientific positions in Q2 2016 and 38 closed out, a net change of +41 holders.
  • The largest Thermo Fisher Scientific buyer in Q2 2016 was Sound Shore Management, an estimated $180M added.
  • The largest Thermo Fisher Scientific seller in Q2 2016 was Royal London Asset Management, an estimated $2.01B sold.

Based on aggregated 13F filings for Q2 2016.